GYNECOLOGY

FRIDAY, DECEMBER 3

08:30-10:00 HRT AND CANCER HALL B
Capsule Is there a relationship between HRT and cancer?
Chairpersons Santiago Palacios, Spain
Sven O. Skouby, Denmark
08:30-08:50 WHO claims, “Estrogens are carcinogenic”. Is this true?
08:50-09:10 Can HRT and treatment for menopause be individualized to reduce the incidence of breast cancer?
Mark Brincat, Malta   
09:10-09:40 Breast cancer in special populations
Herjan Coelingh Bennink, Netherlands
09:40-10:00 HRT in cancer survivors

 

10:00-10:20 Coffee break,  poster viewing and visit the exhibition Exhibition Area

 

10:20-11:50 INDUSTRY SUPPORTED SESSION HALL B

 

11:50-12:10 Break

 

12:10-13:40 VULVAR AND VAGINA HALL B
Capsule
Chairperson Nick Panay, UK 
12:10-12:30 Advances in anatomy and physiology of the vagina based on new treatments
Santiago Palacios, Spain
12:30-12:50 Vulvar pains and co-morbidities: Data from 1183 cases
Alessandra Graziottin, Italy
Capsule Postmenopausal atrophy of the lower genital and urinary tract is distressing and require new ideas to control symptoms
12:50-13:20

12:50
13:00
13:10

Debate:  Is laser effective for treatment of Stress Urinary Incontinence (SUI)

Yes: Zdenko Vizintin, Slovenia
No: Tim Hillard, UK
Discussion

13:20-13:40 Translational medicine in reproductive ageing
Sven O. Skouby, Denmark

 

13:40-14:30  Lunch break,  poster viewing and visit the exhibition Exhibition Area

 

14:30-16:30 PRESCRIBING HRT HALL B
Capsule
Chairpersons Mark Brincat, Malta
Alessandra Graziottin, Italy
Capsule The controversy surrounding androgen addition to HRT  is ongoing
14:30-15:00

14:30
14:40
14:50

Debate: Should androgens be routinely offered to optimize quality of life in menopause?

For: Alessandra Graziottin, Italy
Against:
Discussion

15:15-15:40 Update on practical prescribing of new hormone therapy regimens
Nick Panay, UK
15:40-16:05 New strategies in the prevention of fragility fractures
Santiago Palacios, Spain
16:05-16:30 Use of HRT for cardiovascular prevention
Christian Ergater, Austria

 

16:30-16:50  Coffee break,  poster viewing and visit the exhibition Exhibition Area

 

16:50-18:20 TBA HALL B
Capsule
Chairperson

 

SATURDAY, DECEMBER 4

08:30-10:00 TBA HALL B
Capsule
Chairperson

 

10:00-10:20  Coffee break,  poster viewing and visit the exhibition Exhibition Area

 

10:20-11:50 WOMEN’S HEALTH AND WEALTH
A PREIS SCHOOL ACADEMY SESSION
HALL B
Capsule
Chairperson Gian Carlo Di Renzo, Italy
10:20-10:25 Welcome
Gian Carlo Di Renzo, Italy
10:25-10:35 The Welfare of Women (WoW) global health program endorsed by FIGO
Gian Carlo Di Renzo, Italy
10:35-10:50 Will body-identical MHT become the first choice for menopausal hormone therapy?
10:50-11:05 Testosterone or not Testosterone in menopause: That’s the question!
Nick Panay, UK
11:05-11:20 Which progestogen to optimize breast and endometrial safety in MHT?
Ewald Boschitsch, Austria
11:20-11:50 Discussion

 

11:50-12:00 Break

 

12:00-13:30 IN SEARCH OF NEW PERSPECTIVES: POI MAINLY DRIVEN BY GENETICS HALL B
Capsule
Chairperson Bart Fauser, Netherlands
Nick Panay, UK
12:00-12:25 Is the ovary the mirror of longevity?
Micheline Misrahi, France
12:25-12:45 Genetic architecture of reproductive ageing
Felix Day, UK
12:45-13:05 FMR1 and the genetic control of follliculogenesis
Julia Rehnitz, Germany
13:05-13:30 Endo-ERN and POI
Luca Persani, Italy

 

13:30-14:20 Lunch break,  poster viewing and visit the exhibition Exhibition Area

 

14:20-15:50 TBA HALL B
Capsule
Chairperson

 

15:50-16:00 Break

 

16:00-17:00 TBA HALL B
Capsule
Chairperson